Literature DB >> 27867602

Lung cancer screening: not all nodules are created equal.

Gaurav Shukla1, Noelle L Williams1, Christopher Luminais2, Bo Lu1, Wenyin Shi1.   

Abstract

Entities:  

Year:  2016        PMID： 27867602      PMCID： PMC5107443          DOI： 10.21037/jtd.2016.10.17

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  12 in total

1.  CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.

Authors:  Thibaud P Coroller; Patrick Grossmann; Ying Hou; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Gretchen Hermann; Philippe Lambin; Benjamin Haibe-Kains; Raymond H Mak; Hugo J W L Aerts
Journal:  Radiother Oncol       Date:  2015-03-04       Impact factor: 6.280

2.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

Review 3.  Advances in chemotherapy of non-small cell lung cancer.

Authors:  Julian R Molina; Alex A Adjei; James R Jett
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

4.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

5.  Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Authors:  Nanda Horeweg; Joost van Rosmalen; Marjolein A Heuvelmans; Carlijn M van der Aalst; Rozemarijn Vliegenthart; Ernst Th Scholten; Kevin ten Haaf; Kristiaan Nackaerts; Jan-Willem J Lammers; Carla Weenink; Harry J Groen; Peter van Ooijen; Pim A de Jong; Geertruida H de Bock; Willem Mali; Harry J de Koning; Matthijs Oudkerk
Journal:  Lancet Oncol       Date:  2014-10-01       Impact factor: 41.316

6.  Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.

Authors:  Joan E Walter; Marjolein A Heuvelmans; Pim A de Jong; Rozemarijn Vliegenthart; Peter M A van Ooijen; Robin B Peters; Kevin Ten Haaf; Uraujh Yousaf-Khan; Carlijn M van der Aalst; Geertruida H de Bock; Willem Mali; Harry J M Groen; Harry J de Koning; Matthijs Oudkerk
Journal:  Lancet Oncol       Date:  2016-06-06       Impact factor: 41.316

7.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

8.  Performance of computer-aided detection of pulmonary nodules in low-dose CT: comparison with double reading by nodule volume.

Authors:  Yingru Zhao; Geertruida H de Bock; Rozemarijn Vliegenthart; Rob J van Klaveren; Ying Wang; Luca Bogoni; Pim A de Jong; Willem P Mali; Peter M A van Ooijen; Matthijs Oudkerk
Journal:  Eur Radiol       Date:  2012-07-20       Impact factor: 5.315

9.  NELSON lung cancer screening study.

Authors:  Ying Ru Zhao; Xueqian Xie; Harry J de Koning; Willem P Mali; Rozemarijn Vliegenthart; Matthijs Oudkerk
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

10.  Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

Authors:  Edward F Patz; Erin Greco; Constantine Gatsonis; Paul Pinsky; Barnett S Kramer; Denise R Aberle
Journal:  Lancet Oncol       Date:  2016-03-18       Impact factor: 41.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.